CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CVRx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.35+0.05 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $35.80M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.60 (−86.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CVRx, Inc. grew revenue 12.0% to $61.19M over the twelve months to Jun 30, 2026. Free cash flow was -$41.05M.
Revenue
$61.19M
+12.0% vs. a year earlier
Operating income
-$48.64M
TTM Q2 2026
Free cash flow
-$41.05M
TTM Q2 2026
EPS, diluted
-$1.98
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $35.80M
- P/E ratio
- –
- Price to sales
- 0.59
- Price to book
- 1.79
- Dividend yield
- –
- Free cash flow yield
- -114.69%
Fundamentals
- Revenue
- $61.19M
- Net income
- -$51.97M
- EPS, diluted
- -$1.98
- Free cash flow
- -$41.05M
- Book value per share
- $0.75
- Diluted shares
- 27M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$61.19M+12.0% YoY
Gross profit
$53.18M+16.5% YoY
Operating income
-$48.64M
Net income
-$51.97M
EPS, diluted
-$1.98
Free cash flow
-$41.05M
Reported periodTrailing twelve months